Cargando…

Therapy-Related Acute Myeloid Leukemia 2 Months after Chemoradiotherapy for Esophageal Cancer: A Case Report

Therapy-related acute myeloid leukemia (AML) is a rare but potentially fatal adverse event caused by chemotherapy or radiotherapy. Herein we report a patient diagnosed with therapy-related AML 2 months after chemoradiotherapy for esophageal cancer. A 61-year-old man with dysphagia was diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiraoka, Shinya, Sakanaka, Katsuyuki, Iwai, Takahiro, Fujii, Kota, Inoo, Hiroyuki, Mizowaki, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154239/ https://www.ncbi.nlm.nih.gov/pubmed/32308595 http://dx.doi.org/10.1159/000506449

Ejemplares similares

Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer
por: Inoo, Hiroyuki, et al.
Publicado: (2022)

Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer
por: Fujii, Kota, et al.
Publicado: (2020)

Preoperative chemoradiotherapy for locally advanced low rectal cancer using intensity-modulated radiotherapy to spare the intestines: a single-institutional pilot trial
por: Sakanaka, Katsuyuki, et al.
Publicado: (2021)

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2019)

Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method
por: Ito, Hitoshi, et al.
Publicado: (2017)

Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report
por: Sakanaka, Katsuyuki, et al.
Publicado: (2020)

Effect of long fasting on myocardial accumulation in (18)F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma
por: Ishida, Yuichi, et al.
Publicado: (2018)

Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome
por: Ishida, Yuichi, et al.
Publicado: (2019)

Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2018)

Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2017)

A Case Report of Locally Advanced Anal Cancer with Solitary Cutaneous Nodular Metastasis in the Ipsilateral Labia Majora Treated with Definitive Chemoradiotherapy
por: Sakanaka, Katsuyuki, et al.
Publicado: (2019)

Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution
por: Ogura, Kengo, et al.
Publicado: (2013)

Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control
por: Ogura, Kengo, et al.
Publicado: (2013)

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
por: Narabayashi, Masaru, et al.
Publicado: (2012)

Differences in the dose–volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer
por: Ueki, Nami, et al.
Publicado: (2013)

Reducing variability among treatment machines using knowledge‐based planning for head and neck, pancreatic, and rectal cancer
por: Hirashima, Hideaki, et al.
Publicado: (2021)

Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
por: Araie, Hiroaki, et al.
Publicado: (2023)

GCT-56. ACUTE MYELOID LEUKEMIA FOLLOWING CHEMORADIOTHERAPY FOR INTRACRANIAL GERMINOMA: A CASE REPORT
por: Nakaya, Masato, et al.
Publicado: (2020)

Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer
por: Hatogai, Ken, et al.
Publicado: (2016)

Granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma following chemoradiotherapy and bone marrow transplantation for acute lymphoblastic leukemia
por: Mayanagi, Shuhei, et al.
Publicado: (2013)

Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer
por: Mizowaki, Takashi, et al.
Publicado: (2012)

Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
por: Goto, Yoko, et al.
Publicado: (2018)

Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer
por: Ueda, Hiroto, et al.
Publicado: (2017)

Acute phlegmonous esophagitis as a rare but threatening complication of chemoradiotherapy: report of a case
por: Karimata, Hiroyuki, et al.
Publicado: (2013)

Potent efficacy of chlorpromazine in acute myeloid leukemia harboring KIT-D816V mutation
por: Rai, Shinya, et al.
Publicado: (2021)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Precision therapy for acute myeloid leukemia
por: Yang, Xue, et al.
Publicado: (2018)

Emerging therapies for acute myeloid leukemia
por: Saygin, Caner, et al.
Publicado: (2017)

Therapies for acute myeloid leukemia: vosaroxin
por: Sayar, Hamid, et al.
Publicado: (2017)

Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma
por: Suwa, Tatsuya, et al.
Publicado: (2021)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Non-coplanar volumetric-modulated arc therapy (VMAT) for craniopharyngiomas reduces radiation doses to the bilateral hippocampus: a planning study comparing dynamic conformal arc therapy, coplanar VMAT, and non-coplanar VMAT
por: Uto, Megumi, et al.
Publicado: (2016)

Genital Infection as a First Sign of Acute Myeloid Leukemia
por: Oiso, Naoki, et al.
Publicado: (2010)

The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy
por: Kagami, Takuma, et al.
Publicado: (2020)

A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy
por: Yamada, Kaori, et al.
Publicado: (2018)

Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer
por: Takada, Akinori, et al.
Publicado: (2016)

Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
por: Kumode, Takahiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ptqk296idumk7tinc3qrg7a8u6